SEC Contract Filing

Filing Date: 2024-08-21

Document Content:
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>12
<FILENAME>ea021197601ex10-6_silexion.htm
<DESCRIPTION>FORM OF DIRECTOR AND OFFICER INDEMNIFICATION AGREEMENT, DATED AUGUST 15, 2024, BY AND BETWEEN SILEXION THERAPEUTICS CORP (FORMERLY KNOWN AS BIOMOTION SCIENCES) AND EACH OF ITS EXECUTIVE OFFICERS AND DIRECTORS
<TEXT>
<HTML>
<HEAD>
 <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.6</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM OF INDEMNITY AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>THIS INDEMNITY AGREEMENT </B>(this &ldquo;<B><I>Agreement</I></B>&rdquo;)
is made as of August 15, 2024, by and between Silexion Therapeutics Corp, a Cayman Islands exempted company (the &ldquo;<B><I>Company</I></B>&rdquo;),
and _______ (&ldquo;<B><I>Indemnitee</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">RECITALS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>WHEREAS,</B> the Company has become a publicly-traded
company as a result of the closing of the business combination transaction (the &ldquo;<B><I>Initial Business Combination</I></B>&rdquo;)
contemplated under that certain Amended and Restated Business Combination Agreement, dated as of April 3, 2024, by and among the Company
(formerly known as Biomotion Sciences), Moringa Acquisition Corp, Silexion Therapeutics Ltd., August M.S. Ltd. and Moringa Acquisition
Merger Sub Corp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>WHEREAS, </B>highly competent persons have
become more reluctant to serve publicly-held companies as directors, officers or in other capacities unless they are provided with adequate
protection through insurance or adequate indemnification against inordinate risks of claims and actions against them arising out of their
service to and activities on behalf of such companies;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>WHEREAS</B>, the Board of Directors of the
Company (the &ldquo;<B><I>Board</I></B>&rdquo;) has determined that, in order to attract and retain qualified individuals, the Company
will attempt to maintain on an ongoing basis, at its sole expense, liability insurance to protect persons serving the Company and its
Subsidiaries (as defined below) from certain liabilities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>WHEREAS</B>, while the Amended and Restated
Memorandum and Articles of Association of the Company provide for the indemnification of the officers and directors of the Company, Indemnitee
may also be entitled to indemnification pursuant to applicable Cayman Islands law, and the Amended and Restated Memorandum and Articles
of Association provide that the indemnification provisions set forth therein are not exclusive, and thereby contemplate that contracts
may be entered into between the Company and members of the board of directors, officers and other persons with respect to indemnification,
hold harmless, exoneration, advancement and reimbursement rights;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>WHEREAS</B>, the uncertainties relating to
such insurance and to indemnification have increased the difficulty of attracting and retaining such persons;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>WHEREAS</B>, the Board has determined that
the increased difficulty in attracting and retaining such persons is detrimental to the best interests of the Company&rsquo;s shareholders
and that the Company should act to assure such persons that there will be increased certainty of such protection in the future;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>WHEREAS</B>, it is reasonable, prudent and
necessary for the Company contractually to obligate itself to indemnify, hold harmless, exonerate and to advance expenses on behalf of,
such persons to the fullest extent permitted by applicable law and the Amended and Restated Memorandum and Articles of Association of
the Company so that they will serve or continue to serve the Company free from undue concern that they will not be so protected against
liabilities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>WHEREAS</B>, this Agreement is a supplement
to and in furtherance of the Amended and Restated Memorandum and Articles of Association of the Company and any resolutions adopted pursuant
thereto, and shall not be deemed a substi